Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

NDA just means that UNI can't share Radient's information with anyone else.

There is no non-compete clause that would prevent UNI from selling DR-70 after Radient's last patent expires in five weeks. The new UNI contract says quite specifically that UNI can continue to manufacture and sell DR-70 after that last patent expires.

Incidentally, the agreement between UNI and Radient is not an LOI as you are stating here. LOI stands for Letter of Intent. Radient and UNI have a CONTRACT. And there should be no misinterpretation of the clause that allows UNI to manufacture and sell DR-70 after Radient's last patent expires.